Neo212, a conjugate of TMZ and perillyl alcohol, blocks EndoMT induction in GBM and reverses the mesenchymal phenotype of TDECs by inhibiting both TGF-β and NOTCH pathways. This evidence concerns the gene TGFB1 and glioblastoma.